Amgen, Inc. ( NASDAQ: AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ET Narimon Honarpour - Senior Vice President, Global Development Justin Claeys - ...

In the UK meanwhile, even with the discounted price on offer for Repatha, there have been suggestions that the drug may see its use restricted, with the National Institute for Health and Care ...

Sales of Repatha grew slowly since launch to reach ... New cardiovascular outcomes data has helped the two drugs build a case for broader use, but they are also facing a challenge from a new ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Which of these two high-yield dividend payers is best for your portfolio? Let's weigh their strong points against some of the challenges they face, to see which stock is a better buy now. Where to ...

If this medication contains a substance or requires an administration method that is on the List of Prohibited Substances and Methods (List), you may apply for a Therapeutic Use Exemption (TUE). A TUE ...